BackClearPoint Neuro Overview
ClearPoint Neuro Inc

ClearPoint Neuro Target Price

Analysts' average 12-month price target for ClearPoint Neuro is $21.

Get informed when a big investor buys or sells

+ Follow

Share Price

$15.42

Average Target Price

$21.0036.2% upside

3 analysts in the last 4 months

High: $25 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Lake Street$2562.1% upsideOpen
2026-08-04Stifel NicolausTom Stephan$2242.7% upsideOpen
2026-06-09Stifel NicolausTom Stephan$163.8% upsideOpen
2025-01-21Lake StreetFrank Takkinen$3094.6% upsideOpen
2024-08-27Loop Capital MarketsFrank Takkinen$152.7% downsideOpen
2024-03-13Stifel NicolausMathew Blackman$941.6% downsideOpen

ClearPoint Neuro (CLPT) FAQ

ClearPoint Neuro's target price stands at $21. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $21 for CLPT implies 36.2% upside versus today's price ($15.42). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how ClearPoint Neuro's target price evolved across reporting periods, while the comparison chart places CLPT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. ClearPoint Neuro's reading of $21 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.